Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

December 9, 2022

Winship Cancer Institute of Emory University study finds Black women have worst HR+/HER2- breast cancer outcomes of all racial and ethnic groups

Kevin Kalinsky, MD, MS, of Winship Cancer Institute of Emory University recently presented clinical trial findings that found that non-Hispanic Black (Black) women with Hormone Receptor positive/HER2-negative breast cancer, with 1-3 involved lymph nodes and recurrence scores below 25, have worse outcomes than non-Hispanic white women with similar diagnosis. Even though HR+/HER2 breast cancer if diagnosed early, is one the most survivable.

“These data demonstrate that there is a difference in outcome based on race/ethnicity in a large, randomized trial,” says Kalinsky, “Understanding why is critical, as is increasing the number of underrepresented minorities in clinical trials.”

Emory Healthcare is a foundational partner of AccessHope.

Read the article. 

 

 

 

Previous

Next